EP1098858A1 - Synthetische glasfasern - Google Patents
Synthetische glasfasernInfo
- Publication number
- EP1098858A1 EP1098858A1 EP99932758A EP99932758A EP1098858A1 EP 1098858 A1 EP1098858 A1 EP 1098858A1 EP 99932758 A EP99932758 A EP 99932758A EP 99932758 A EP99932758 A EP 99932758A EP 1098858 A1 EP1098858 A1 EP 1098858A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- fibres
- amount
- product according
- composition
- feo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 claims abstract description 31
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 14
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 claims abstract description 12
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052681 coesite Inorganic materials 0.000 claims abstract description 9
- 229910052906 cristobalite Inorganic materials 0.000 claims abstract description 9
- 229910052682 stishovite Inorganic materials 0.000 claims abstract description 9
- 229910052905 tridymite Inorganic materials 0.000 claims abstract description 9
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910052593 corundum Inorganic materials 0.000 claims abstract description 4
- 229910001845 yogo sapphire Inorganic materials 0.000 claims abstract description 4
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 239000000155 melt Substances 0.000 description 9
- 238000004090 dissolution Methods 0.000 description 8
- 238000009413 insulation Methods 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000835 fiber Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000004576 sand Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002893 slag Substances 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000006004 Quartz sand Substances 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 229910052599 brucite Inorganic materials 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000005183 environmental health Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000010450 olivine Substances 0.000 description 1
- 229910052609 olivine Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000007575 rotation viscometry Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 239000010456 wollastonite Substances 0.000 description 1
- 229910052882 wollastonite Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C13/00—Fibre or filament compositions
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C2213/00—Glass fibres or filaments
- C03C2213/02—Biodegradable glass fibres
Definitions
- the present invention concerns man-made vitreous fibres (MMVF) , which have a solubility in biological fluid (biosolubility) which is considered to be acceptable, which are durable in use and which give good fire resistance properties.
- MMVF man-made vitreous fibres
- MMV fibres from mineral melt.
- a combination of raw materials is melted in a furnace to provide a mineral melt having the desired chemical composition and is then formed into fibres. These are used for various purposes including heat insulation, fire protection, sound insulation etc.
- MMV fibres which can be said to be of improved biological safety.
- Biological safety is usually measured on the basis of an in vitro test which assesses the dissolution rate of the fibres in a liquid which is intended to simulate lung liquid, such as Gamble's solution at about pH 7.5.
- fibres disclosed in, in particular, W095/21799 have proved to be interesting and valuable as fibres which are soluble in biological media
- improved biological solubility In particular there is a desire to achieve improved biological solubility when determined by in vivo tests. It is also desirable to achieve this biological solubility together with ease and efficiency of manufacture and with good physical properties of the fibres.
- one method for determining biosolubility is by intra-tracheal tests, as described e.g.
- a T 50 of less than or equal to 65 days is normally satisfactory at present but it would be desirable to produce fibres having even lower T 50 .
- a product comprising man-made vitreous fibres formed from a composition which includes, by weight of oxides,
- this particular combination of components in the defined amounts in particular the selected ranges of FeO, Al 2 0 3 and alkali metal (Na 2 0 + K 2 0) , especially the narrow range of FeO, give a good combination of durability in use and biosolubility. It is particularly surprising that biosolubility can be obtained with the very low levels of alkali metal, since these elements tend to enhance biosolubility.
- the fibres can be produced from readily available starting materials and the fibres have good thermal stability, fire resistance and insulation properties.
- the amount of Si0 2 is from 46 to 58%. Usually it is at least 50%, preferably at least 54%. In some cases it can be preferred that Si0 2 is not more than 56%.
- the amount of A1 2 0 3 is from 0.8 to 3%. Usually it is at least 0.9 or at least 1%. In some cases it may be at least 1.1%. In general it is not more than 2.5%, preferably not more than 2%.
- the amount of FeO is from 5 to 6.8%. In particular it is often at least 5.5%.
- the iron should mainly be in the ferrous state (rather than in the ferric state) .
- at least 70%, more preferably at least 80%, of the iron is ferrous.
- at least 90 or 95% by weight of the iron is present in ferrous form in the product of the invention.
- the amount of Ti0 2 is not more than 4%. It may be at least 0.2%, preferably at least 0.5%. In some compositions it can be at least 0.8 or 1%. It is generally not more than 2% and preferably not more than 1.5%. In some cases it is preferably not more than 0.5 or 0.2%.
- the amount of CaO is from 0 to 40%. Generally it is at least 10%, preferably at least 15%. In general it is not more than 30 or 25%. It can be not more than 20% but in some cases amounts of at least 20% are beneficial, in particular if MgO is below 10 or 8%.
- the amount of MgO is from 0 to 30%. It may be at least
- the total amount of alkali metal (Na 2 0 + K 2 0) in the invention is very low and ranges from 0 to 1%. In particular it is not more than 0.8%, preferably not more than 0.6%. Generally the amount of Na 2 0 + K 2 0 is at least 0.1%, and can be at least 0.2%, although in some preferred cases it is particularly low and is below 0.2%.
- the fibres must contain P 2 0 5 . It is present in an amount of 0.2 to 10%. In some fibres preferred according to the invention the amount is not more than 5%, preferably not more than 4%.
- the amount of P 2 0 5 can preferably be not more than 2%. In these cases it is particularly surprising that we obtain good biosolubility properties, since it has been stated in various publications that the inclusion of a high amount of P 2 0 5 is required to achieve good biosolubility.
- the amount of P 2 0 5 is preferably at least 0.5%.
- the amount of P 2 0 5 can in some cases be from 0.2 to 3%. In other preferred compositions the amount of P 2 0 5 is at least 4%.
- the ratio of P 2 0 5 / (A1 2 0 3 + FeO) is preferably not more than 0.8, more preferably not more than
- solubility (based on wt.% of each oxide) is at least 25. Preferably it is at least 30, more preferably at least 31, most preferably at least 32 or 33. It may in particular be at least 34. This is necessarily an approximation and solubility should be determined experimentally using an appropriate protocol, but we find in general that as the value of this sum increases, the solubility of the fibres can increase.
- the fibres in the product of the invention may contain various other elements in a total amount up to 10%.
- the amount of other elements is not more than 6%, more preferably not more than 3% and in particular not more than 2%.
- Other elements which can be contained in the fibres include B 2 0 3 , BaO, Zr0 2 , MnO, ZnO, F, Cl, Cr 2 0 3 and V 2 0 5 . If B 2 0 3 is present it is usually present in an amount of not more than 5%. In particular the amount of B 2 0 3 is preferably less than the amount of P 2 0 5 .
- melt viscosity is viscosity in poise at 1400°C, measured by rotation viscometry or calculated according to Bottinga and Weill, American Journal of Science, Volume 272, May 1972, pages 455 to 475. Since P 2 0 5 is not included in this calculation the presence of P 2 0 5 is taken into consideration by equalising 1 mole % of P 2 0 5 with 2 mole % Si0 2 plus 1 mole % CaO. Laboratory tests have shown that this approximation is valid within actual chemical ranges.
- the composition of the invention preferably provides a melt which has viscosity at 1400°C at least 10 poise, preferably at least 15 poise and often at least 17 poise. Although it may be as high as 60 poise, generally it is not more than 40 poise and preferably is not more than 30 poise. The range of 24 to 28 poise is advantageous.
- the viscosity can be not more than 25 poise and in particular not more than 20 poise.
- biosolubility is measured in terms of dissolution rate in Gamble's solution.
- Dissolution rate is determined by a flow-through technique, as follows.
- the modified Gamble's solution used has the following composition : all
- the fibre diameter distribution is determined for each sample by measuring the diameter of at least 200 individual fibres by means of the intercept method and a scanning electron microscope or optical microscope (100 x magnification) .
- the readings are used for calculating the specific surface of the fibre samples, taking into account the density of the fibres.
- the calculations are based on the Si0 2 content in the fibres, the specific surface and the dissolved amount of Si.
- the dissolution rate by the flow-through method is determined as follows. lO g of fibres are placed in a flow cell in a polycarbonate filter holder (diameter, 40 mm) .
- 0.8 ⁇ m filter is placed on the inlet side (top) and a 0.2 ⁇ m filter is placed on the outlet side (bottom) to avoid loss of fibres during the test. Both filters are made of cellulose nitrate.
- the flow rate of the modified Gamble's solution is around 200ml/day and is maintained at this rate by a peristaltic pump.
- the ratio of liquid flow to surface area of the fibres is 1 to 2 ⁇ m/second.
- the pH of the solution is maintained at 7.6 ⁇ 0.2 by bubbling with N/C0, (95/5) .
- the entire set-up, including storage containers, is maintained at 37 ⁇ 0.7°C. Effluent solution is collected once a week for a two hour period and analysed for Si and Ca. Analyses are made on a Perkin-Elmer atomic absorption spectrophotometer (AAS) . Further details are given in Environmental Health Perspectives, Volume 102, Supplement 5, October 1994, page 83.
- the fibres preferably have solubility measured by this test of at least 60 nm/day, more preferably at least 80 or lOOnm/day. More preferably the solubility is at least 120 or 130nm/day. It may even be at least 150 or 160nm/day.
- the fibres of the invention preferably have T 50 not more than 60, more preferably not more than 50 and in particular not more than 45, especially not more than 40.
- the fibre products of the invention are made in conventional manner.
- the composition is usually formed by blending appropriate amounts of naturally occurring raw materials, such as rock and sand materials and recovered waste materials. These include converter slag, other slags, glass, foundry sand, limestone, magnesite, brucite, talc, serpentinite, pyroxenite, apatite, wollastonite, quartz sand, olivine sand, iron ore, dolomite, and MMVF waste.
- the composition can be converted to a melt in conventional manner, for instance by melting the raw materials in an electric furnace or in a cupola furnace.
- the melt is preferably produced in a cupola furnace.
- the melt is formed into fibres by conventional processes comprising pouring the melt into or onto a rapidly spinning fiberising rotor and causing the melt to be flung from the periphery of the rotor as fibres.
- the rotor may be a spinning cup type of rotor or a rotor having a solid periphery which is usually mounted about a substantial horizontal axis. Rotors of this type can be arranged as a cascade system.
- the fibres can be formed into MMVF in conventional manner by laying down the fibres in the presence of binder typically in an amount of from 0.5 to 4%, often around 1 to
- the products may be used for any of the purposes for which MMVF products are known. These include thermal insulation, fire insulation and protection, noise reduction and regulation, horticultural growing media or as free fibres for reinforcement of cement, plastics or other products or as a filler. They may be provided in any of the conventional forms such as slabs or batts, sheets, pipe sections or other shaped products, or may be comminuted to a granular product.
- raw materials are melted to form a melt which has the composition given below in Table 1.
- the melt is formed into fibres by means of a cascade rotor system.
- the fibres are collected as an air laid web and treated to form a product.
- the melt viscosity at 1400°C is given below for each composition.
- For each fibre composition the solubility under the in vitro test discussed above is also given.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Geochemistry & Mineralogy (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Glass Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9814179.9A GB9814179D0 (en) | 1998-06-30 | 1998-06-30 | Man-made vitreous fibres |
GB9814179 | 1998-06-30 | ||
PCT/EP1999/004513 WO2000000444A1 (en) | 1998-06-30 | 1999-06-30 | Man-made vitreous fibres |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1098858A1 true EP1098858A1 (de) | 2001-05-16 |
Family
ID=10834705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99932758A Withdrawn EP1098858A1 (de) | 1998-06-30 | 1999-06-30 | Synthetische glasfasern |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1098858A1 (de) |
AU (1) | AU4902899A (de) |
CA (1) | CA2335591A1 (de) |
DE (1) | DE19840397A1 (de) |
GB (1) | GB9814179D0 (de) |
HU (1) | HUP0102949A2 (de) |
PL (1) | PL345280A1 (de) |
WO (1) | WO2000000444A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004014344B4 (de) * | 2004-03-22 | 2008-06-19 | Saint-Gobain Isover G+H Ag | Biologisch abbaubare Glaszusammensetzung und Mineralwolleprodukt hieraus |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2690438A1 (fr) * | 1992-04-23 | 1993-10-29 | Saint Gobain Isover | Fibres minérales susceptibles de se dissoudre en milieu physiologique. |
SK281347B6 (sk) * | 1994-02-11 | 2001-02-12 | Rockwool International A/S | Výrobok obsahujúci sklenené umelé vlákna |
GB9426429D0 (en) * | 1994-12-30 | 1995-03-01 | Rockwool Int | Man-made vitreous fibres |
GB2301351A (en) * | 1995-08-16 | 1996-12-04 | Rockwool Int | Process for the production of saline-soluble vitreous fibres |
FI109294B (sv) * | 1997-03-10 | 2002-06-28 | Paroc Group Oy Ab | Mineralfiber |
-
1998
- 1998-06-30 GB GBGB9814179.9A patent/GB9814179D0/en not_active Ceased
- 1998-09-04 DE DE19840397A patent/DE19840397A1/de not_active Withdrawn
-
1999
- 1999-06-30 WO PCT/EP1999/004513 patent/WO2000000444A1/en not_active Application Discontinuation
- 1999-06-30 PL PL99345280A patent/PL345280A1/xx unknown
- 1999-06-30 AU AU49028/99A patent/AU4902899A/en not_active Abandoned
- 1999-06-30 EP EP99932758A patent/EP1098858A1/de not_active Withdrawn
- 1999-06-30 CA CA002335591A patent/CA2335591A1/en not_active Abandoned
- 1999-06-30 HU HU0102949A patent/HUP0102949A2/hu unknown
Non-Patent Citations (1)
Title |
---|
See references of WO0000444A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE19840397A1 (de) | 2000-01-05 |
PL345280A1 (en) | 2001-12-03 |
HUP0102949A2 (hu) | 2001-11-28 |
CA2335591A1 (en) | 2000-01-06 |
AU4902899A (en) | 2000-01-17 |
GB9814179D0 (en) | 1998-08-26 |
WO2000000444A1 (en) | 2000-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0698001B1 (de) | Synthetische glasfasern | |
CA2204772C (en) | Man-made vitreous fibres | |
CA2152920C (en) | Thermostable and biologically soluble mineral fibre compositions | |
US5332699A (en) | Inorganic fiber composition | |
EP0621858B1 (de) | Verwendung anorganischer fasern, löslich in einer salzlösung, als isoliermaterial | |
AU2002324024C1 (en) | Biosoluble ceramic fiber composition with improved solubility in a physiological saline solution for a high temperature insulation material | |
WO1997031870A1 (en) | Man-made vitreous fibres | |
EP1048625A1 (de) | Biolösliche Glasfaser-Zusammensetzung für die Herstellung von Glaswollen und dergleichen | |
EP0675858B1 (de) | Thermostabile und biolösliche mineralfaserzusammensetzungen | |
WO2000000444A1 (en) | Man-made vitreous fibres | |
EP0766654B1 (de) | Thermostabile und biolösliche faserzusammensetzungen | |
WO2001060754A1 (en) | Man-made vitreous fibres and products containing them | |
AU704242C (en) | Man-made vitreous fibres | |
WO2000073230A1 (en) | Man-made vitreous fibres and products containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20001227 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE DE ES FI FR GB NL SE |
|
17Q | First examination report despatched |
Effective date: 20011017 |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
RTI1 | Title (correction) |
Free format text: MAN-MADE VITREOUS FIBRES AND THEIR USE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030208 |